Assessment of ovarian tumor marker CA-125 during radiotherapy course

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Journal of Experimental and Clinical Medicine
Volume:30 Issue:2
Assessment of ovarian tumor marker CA-125 during radiotherapy course

Assessment of ovarian tumor marker CA-125 during radiotherapy course

Authors : Mohammed ALIOMER, Mohamed MOHAMED, Mohamed YOUSEF, Mohammed FARAHNA, Adel ALGHANIM

Pages : 137-139

Doi:10.5835/jecm.omu.30.02.010

View : 38 | Download : 10

Publication Date : 2013-07-31

Article Type : Research Paper

Abstract :The antigen secretion by ovarian cancer insert ignore into journalissuearticles values(CA-125); has been assessed using Radio Immune Assay insert ignore into journalissuearticles values(RIA); technique among a hundred ovarian cancer patients who received radiotherapy course as radical treatment. The study revealed that, the ovarian cancer commonly associated with the age groups of 30-40 years old taking a percent of 68 relative to other age groups and the antigen CA-125 does not has relation with aging. While the radiotherapy shows it is efficiency in management of ovarian cancer by reducing the antigen CA-125 level from 134 ± 13.3 U/ml to 5.5 ± 2.1 U/ml relative to normal level of CA-125 insert ignore into journalissuearticles values(35 U/ml);. Also there is significant relationship between the cancer stage and the level of antigen CA-125 insert ignore into journalissuearticles values(R2=0.98);.
Keywords : Ovarian cancer, Radiation therapy and tumor maker, Radioimmuneassay

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.